These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9263851)

  • 1. A Monte Carlo method for finding important ligand fragments from receptor data.
    Burt S; Hutchins C; Zielinski PJ
    J Comput Aided Mol Des; 1997 May; 11(3):243-55. PubMed ID: 9263851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to calculate water binding free energies in protein-ligand complexes.
    Bodnarchuk MS; Viner R; Michel J; Essex JW
    J Chem Inf Model; 2014 Jun; 54(6):1623-33. PubMed ID: 24684745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grand canonical Monte Carlo simulation of ligand-protein binding.
    Clark M; Guarnieri F; Shkurko I; Wiseman J
    J Chem Inf Model; 2006; 46(1):231-42. PubMed ID: 16426059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding Modes of Ligands Using Enhanced Sampling (BLUES): Rapid Decorrelation of Ligand Binding Modes via Nonequilibrium Candidate Monte Carlo.
    Gill SC; Lim NM; Grinaway PB; Rustenburg AS; Fass J; Ross GA; Chodera JD; Mobley DL
    J Phys Chem B; 2018 May; 122(21):5579-5598. PubMed ID: 29486559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydration of ligands of influenza virus neuraminidase studied by the fragment molecular orbital method.
    Tokuda K; Watanabe C; Okiyama Y; Mochizuki Y; Fukuzawa K; Komeiji Y
    J Mol Graph Model; 2016 Sep; 69():144-53. PubMed ID: 27611645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the binding energy for small molecules, peptides and proteins.
    Schapira M; Totrov M; Abagyan R
    J Mol Recognit; 1999; 12(3):177-90. PubMed ID: 10398408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational free energy surface of alpha-N-acetylneuraminic acid: an interplay between hydrogen bonding and solvation.
    Spiwok V; Tvaroska I
    J Phys Chem B; 2009 Jul; 113(28):9589-94. PubMed ID: 19374421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for computing protein binding affinity.
    Karney CF; Ferrara JE; Brunner S
    J Comput Chem; 2005 Feb; 26(3):243-51. PubMed ID: 15614799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: application to influenza neuraminidase.
    Bonnet P; Bryce RA
    J Mol Graph Model; 2005 Oct; 24(2):147-56. PubMed ID: 16098779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the affinity and specificity of ligand binding with the inclusion of solvation effect.
    Yan Z; Wang J
    Proteins; 2015 Sep; 83(9):1632-42. PubMed ID: 26111900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes.
    Wang T; Wade RC
    J Med Chem; 2001 Mar; 44(6):961-71. PubMed ID: 11300878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-sheet folding of fragment (16-36) of bovine pancreatic trypsin inhibitor as predicted by Monte Carlo simulated annealing.
    Nakazawa T; Kawai H; Okamoto Y; Fukugita M
    Protein Eng; 1992 Sep; 5(6):495-503. PubMed ID: 1279665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QXP: powerful, rapid computer algorithms for structure-based drug design.
    McMartin C; Bohacek RS
    J Comput Aided Mol Des; 1997 Jul; 11(4):333-44. PubMed ID: 9334900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico study of carvone derivatives as potential neuraminidase inhibitors.
    Jusoh N; Zainal H; Abdul Hamid AA; Bunnori NM; Abd Halim KB; Abd Hamid S
    J Mol Model; 2018 Mar; 24(4):93. PubMed ID: 29546582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin.
    Stultz CM; Karplus M
    Proteins; 2000 Aug; 40(2):258-89. PubMed ID: 10842341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?
    Michel J; Verdonk ML; Essex JW
    J Med Chem; 2006 Dec; 49(25):7427-39. PubMed ID: 17149872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionality maps of binding sites: a multiple copy simultaneous search method.
    Miranker A; Karplus M
    Proteins; 1991; 11(1):29-34. PubMed ID: 1961699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of proximal His93 in nitric oxide binding to metmyoglobin. Application of continuum solvation in Monte Carlo protein simulations.
    Keserü GM; Menyhárd DK
    Biochemistry; 1999 May; 38(20):6614-22. PubMed ID: 10350480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.